Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Portugal,France,Serbia,Germany,Poland,Slovakia,Italy,United Kingdom,Bulgaria - Promoter: Martin Kropff, MD
Martin Kropff, MD
Update Il y a 5 ans
Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma
The primary objective is to compare the time to progression (TTP) of three daily doses of thalidomide (100, 200 and 400 mg) with high-dose dexamethasone in relapsed refractory multiple myeloma (MM) patients and to subsequently select the optimum thalidomide dose in terms of median TPP and toxicity.
Country
Bulgaria
,
Croatia
,
Czech Republic
,
France
,
Germany
,
Hungary
,
India
,
Italy
,
Philippines
,
Poland
,
Portugal
,
Serbia
,
Slovakia
,
South Africa
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
1